Document Detail

Developmental outcome in very low birthweight infants. Current status and future trends.
MedLine Citation:
PMID:  9653444     Owner:  NLM     Status:  MEDLINE    
Surfactant therapy has significantly reduced mortality, but not morbidity, in the very low birthweight (VLBW) infant. Questions persist as to the edge of viability, the allocation of health care resources for the VLBW infant, and whether or not we are improving survival at the cost of contributing more handicapped individuals to society. Since surfactant alone has not reduced morbidity, other medical and behavioral treatments are being studied that may help to optimize neurodevelopmental outcome in the VLBW infant.
J Bregman
Related Documents :
10863124 - The role of linked birth and infant death certificates in maternal and child health epi...
2472134 - Neonatal cranial ultrasonography as predictor of 2 year outcome of very low birthweight...
3814554 - Does conception before marriage matter?
24494514 - Operative vaginal delivery at port moresby general hospital from 1977 to 2010.
24739494 - Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repai...
24932094 - Transient complete atrioventricular block in a preterm neonate with congenital myotonic...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pediatric clinics of North America     Volume:  45     ISSN:  0031-3955     ISO Abbreviation:  Pediatr. Clin. North Am.     Publication Date:  1998 Jun 
Date Detail:
Created Date:  1998-07-16     Completed Date:  1998-07-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401126     Medline TA:  Pediatr Clin North Am     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  673-90     Citation Subset:  AIM; IM    
Department of Pediatrics, Evanston Northwestern Healthcare, Evanston Hospital, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis
Developmental Disabilities / etiology*,  prevention & control
Infant, Newborn
Infant, Very Low Birth Weight*
Pulmonary Surfactants / economics,  therapeutic use*
Respiratory Distress Syndrome, Newborn / complications,  drug therapy*,  mortality
Survival Analysis
Treatment Outcome
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Principles of disease management in neonatology.
Next Document:  The death of a baby in the infant special care unit.